Browse by title
Edited by Duncan Matthews and Herbert Zech
Handbook Chapter
In Research Handbook on Intellectual Property and the Life Sciences
Edited by Duncan Matthews and Herbert Zech
- Published in print:
- 30 Jun 2017
Collection:
Law 2017
Handbook Chapter
In Research Handbook on Intellectual Property and the Life Sciences
Edited by Duncan Matthews and Herbert Zech
- Published in print:
- 30 Jun 2017
Collection:
Law 2017
Edited by Duncan Matthews and Herbert Zech
Handbook Chapter
In Research Handbook on Intellectual Property and the Life Sciences
Edited by Duncan Matthews and Herbert Zech
- Published in print:
- 30 Jun 2017
Collection:
Law 2017
Introduction
The Requirement of Industrial Application
Marta Díaz Pozo
This chapter provides a general introduction to the book. The chapter reviews the historical development of the biotechnology industry and the difficulties in applying conventional European patent law rules to genetic inventions. In particular, the chapter presents the concerns regarding the lack of industrial application of patent claims over isolated human DNA sequences and the importance of this requirement in the patenting of inventions concerning human genes.
Monograph Chapter
In Patenting Genes
Marta Díaz Pozo
- Published in print:
- 31 Mar 2017
Collection:
Law 2017
Helen Yu
Chapter 1 introduces the problem with respect to the current drug development process. The integrated drug discovery model is introduced as a potential solution to bridge the translational gap by achieving proof of concept as a way to demonstrate the clinical and commercial viability of basic research. However, this collaboration between industry and public research organizations may give rise to a violation of competition law due to anticompetitive or exclusionary conduct, such as but not limited to, exclusivity agreements with industry partners, grant back restrictions, and refusal to license to third parties. Furthermore, although the bringing together of complementary skills and assets in a collaboration between industry and integrated drug discovery organizations may facilitate innovation by enhancing efficiency and reducing expenditure, the number and ability of potential market actors to enter the market may be limited by such collaboration. In other words, the exercise of intellectual property rights may give rise to anticompetitive effects under certain circumstances.
Monograph Chapter
In Achieving Proof of Concept in Drug Discovery and Development
Helen Yu
- Published in print:
- 25 Nov 2016
Collection:
Law 2016
Monograph Chapter
In Genetics, Crime and Justice
Debra Wilson
- Published in print:
- 28 Aug 2015
Collection:
Law 2015
Monograph Chapter
In Genetics, Crime and Justice
Debra Wilson
- Published in print:
- 28 Aug 2015
Collection:
Law 2015
Andrea Stazi
Monograph Chapter
In Biotechnological Inventions and Patentability of Life
Andrea Stazi
- Published in print:
- 29 May 2015
Collection:
Law 2015
Monograph Chapter
In Biotechnological Inventions and Patentability of Life
Andrea Stazi
- Published in print:
- 29 May 2015
Collection:
Law 2015
Monograph Chapter
In Boosting Pharmaceutical Innovation in the Post-TRIPS Era
Burcu Kilic
- Published in print:
- 25 Jul 2014
Collection:
Law 2014